XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Breast Channel
subscribe to Breast newsletter

Latest Research : Cancer : Breast

   DISCUSS   |   EMAIL   |   PRINT
Breast cancer's genetic signature predicts likelihood and location of spread
Jan 4, 2005, 19:36, Reviewed by: Dr.



 
Cancer metastasis � the transfer of disease from one organ to another not directly connected to it � is responsible for the majority of cancer-related deaths. It is believed that metastases arise from rare cells in the original tumor that acquire the ability to grow at a distant site. Previous studies using microarray technology � which allows researchers to determine the expression levels of genes within cells and is often described as a gene expression "signature" � have revealed that expression of a set of 70 genes in the primary tumors of breast cancer patients, called the "poor prognosis" signature, is highly predictive of the development of breast cancer spread and patient survival.

Using this technology, Joan Massag� and colleagues from Memorial Sloan-Kettering Cancer Center, New York, examined the potential of individual breast cancer cells to spread to distinct and different organs. The authors found that breast cancer cells did indeed carry the poor-prognosis signature and this signature differed little between cells. However breast cancer cells had varying abilities to spread to bone, lung, and the adrenal gland. Most interestingly, the authors found that the genes that make up the poor-prognosis signature were different to those that comprised the metastatic signature, indicating that the genes that make up the poor-prognosis signature do not control the ability of the tumor to spread to specific organs. Furthermore, they identified a bone metastasis gene expression signature that was able to distinguish between primary breast carcinomas that preferentially spread to bone from those that spread elsewhere. Use of this gene expression signature may in the future allow accurate prediction of the spread of breast cancer primary tumors to bone and subsequently help guide the treatment of breast cancers.

 

- The study is reported in the January 3 issue of the Journal of Clinical Investigation.
 

A PDF of this article this article is available at: http://www.jci.org/cgi/content/full/115/1/44.

 
Subscribe to Breast Newsletter
E-mail Address:

 

TITLE: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

AUTHOR CONTACT: Joan Massagu�
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Phone: 212-639-8975; Fax: 212-717-3298; E-mail: [email protected].


Related Breast News

Breast cancer chemotherapy may deterioration in cognitive function
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers set benchmarks for screening mammography
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels
Physical activity improves survival in breast cancer patients
Pedigree assessment tool correctly identifies women with higher risk of breast cancer
MRI more accurately determines cancer spread into breast ducts
Core needle biopsy gives an accurate picture of gene expression


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us